Angtai Gastrointestinal Endoscopy Robot
Angtai Microfine is developing a transendoscopic surgical robot system that extends the company’s ultra-precision platform technology to gastrointestinal applications. This pipeline product applies the same tremor-elimination and sub-micrometer precision capabilities proven in the company’s microsurgical and ophthalmic robot platforms.
Product Overview
The gastrointestinal endoscopy robot represents an extension of Angtai Microfine’s core technology platform into interventional gastroenterology. While specific product details remain limited as the system is in development, the company has indicated this robot will use its proprietary tremor-free drive systems and precision instrument technology for transendoscopic procedures.
The system is designed to address precision requirements in gastrointestinal interventions where human hand control limitations may affect procedure outcomes.
Development Status
As of available information:
- The product is in the research and development phase
- Type testing was originally planned for the year following the company’s Series A funding (2022)
- Current development status has not been publicly updated
Technology Platform
The gastrointestinal endoscopy robot is expected to incorporate Angtai Microfine’s core technologies:
- Tremor-free operation system
- Sub-micrometer motion precision
- Compact instrument design
- Multi-degree-of-freedom manipulation
Regulatory Status
| Region | Status | Date |
|---|---|---|
| China (NMPA) | Not Applied | - |
| Europe (CE) | Not Applied | - |
| USA (FDA) | Not Applied | - |
The product remains in development and has not entered regulatory submission.
Frequently Asked Questions
What is the current status of this product?
The gastrointestinal endoscopy robot is in the research and development phase. Angtai Microfine has prioritized its general-purpose microsurgical robot (Kai) and ophthalmic robot for initial regulatory submissions.
What procedures will this robot target?
Specific indications have not been publicly disclosed. Based on the company’s focus on ultra-precision surgery, the system is expected to address gastrointestinal procedures requiring precision beyond standard endoscopic techniques.
When will this product be available?
No timeline for regulatory submission or commercial availability has been announced.
Browse related categories
Sources
Publicly available references used for the data on this page. See data methodology for verification standards.